Important announcement on Hong Kong stocks:

1) Company News

$CHINA LIFE (02628.HK)$: Completed the issuance of capital replenishment bonds totaling 35 billion yuan.

The announcement stated that the type of bonds in this issuance is 10-year fixed-rate bonds with a face interest rate of 2.15%, used to supplement the company's tier one capital and enhance the company's solvency.

$NEW WORLD DEV (00017.HK)$: Zheng Zhigang has submitted his resignation as the company's CEO, and Ma Shaoxiang has been appointed as the company's CEO.

Information shows that Zheng Zhigang was once considered the third-generation successor of Hong Kong's New World Group and has been the CEO of New World Development since 2017. Ma Shaoxiang was originally the Chief Operating Officer of New World Development. Before joining New World Development, he served as the Deputy Director of the Development Bureau of the Hong Kong Special Administrative Region government in January 2014, and was later appointed as the Director of the Development Bureau in February 2017.

In addition, New World Development announced its annual performance as of June 30, 2024, with revenue of 35.8 billion Hong Kong dollars, a 34% year-on-year decrease, and a net income of 6.9 billion Hong Kong dollars, an 18% year-on-year decrease. The company is also in discussions regarding the potential sale of all shares held by the group in KTSPL to Chow Tai Fook Enterprises.

$CHOW TAI FOOK (01929.HK)$ Zheng Zhigang has submitted his resignation as an executive director of the company, effective from September 26, 2024, in order to devote more time to public services and other personal matters.

$GUOCO GROUP (00053.HK)$Announced financial performance for the year ended June 30, 2024, with revenue of 25.786 billion Hong Kong dollars, a 17% year-on-year increase; net income of 3.581 billion Hong Kong dollars, a 4% year-on-year increase. Mainly driven by strong sales of residential projects in Singapore, and increased earnings from the hotel and leisure division.

$HSBC HOLDINGS (00005.HK)$Completed the issuance of the first privately placed digital bonds in Hong Kong, totaling 1 billion Hong Kong dollars.

$TG SMART ENERGY (01083.HK)$The affiliated TG Gas Investment entered into a merger agreement with Shandong Guo, Shandong Jihua, Jinan Energy Group, and Zhonghua Gas (Jinan).

$JACOBIO-B (01167.HK)$The new drug Pan-KRAS inhibitor AB-23E73 independently developed has obtained clinical trial approval in China.

The announcement stated that KRAS is widely present in various tumor mutations, approximately 23%-25% of cancer patients have KRAS mutations, and about 2.7 million new cancer patients with KRAS-related mutations globally each year are expected to benefit from Pan-KRAS inhibitors.

$JUNSHI BIO (01877.HK)$JS125 has obtained a drug clinical trial approval notification.

2) Repurchase Dynamics

$TENCENT (00700.HK)$Invested 0.151 billion Hong Kong dollars to repurchase 0.3674 million shares, with a repurchase price of 407.0-414.2 Hong Kong dollars.

$MEITUAN-W (03690.HK)$Invested 61.1632 million Hong Kong dollars to repurchase 0.4268 million shares, with a repurchase price of 142.6-143.5 Hong Kong dollars.

$MNSO (09896.HK)$Invested 15.4826 million Hong Kong dollars to repurchase 0.5218 million shares, with a repurchase price of 28.35-30.9 Hong Kong dollars.

$CEB BANK (06818.HK)$The controlling shareholder, China Everbright Group, has cumulatively increased its A-share holdings by 80.6195 million shares.

$WUXI APPTEC (02359.HK)$Invested 36.8909 million yuan to repurchase 0.8829 million A shares.

$ANTA SPORTS (02020.HK)$Canceled 3.3972 million shares of repurchased shares.

Editor/ping